Latest news
Loading news…
Icon Bioscience develops and commercializes novel ophthalmic pharmaceuticals through a proprietary drug delivery platform.
Icon Bioscience was acquired by EyePoint Pharmaceuticals in 2018.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Sunnyvale, California, United States
Key People at Icon Bioscience
Chairman/Founder
CEO
5
professional contacts at Icon Bioscience
Contact execs at Icon Bioscience →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Icon Bioscience
Loading news…
FAQs about Icon Bioscience
People who checked this page also checked these
Browse the full Acquirezy directory.